AstraZeneca, Daiichi Drug gets broad tumor approval in US
Enhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread throughout the body, marking a breakthrough in cancer treatment. It's the first antibody drug conjugate with such wide clearance, offering new hope for patients with limited treatment options. AstraZeneca anticipates further growth opportunities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2024 Category: Pharmaceuticals Source Type: news

PET/MRI detects brain injury in pediatric cancer survivors
PET/MRI could be a tool for diagnosing brain injury in young cancer survivors due to high-dose methotrexate treatment, according to pediatric radiologists at Stanford University in Stanford, CA. In a pilot study in 10 children and young adults, F-18 FDG-PET/MRI detected brain injury based on reductions in glucose metabolism and blood flow in specific brain areas. The imaging findings could facilitate earlier treatments in these patients, noted lead author Lucia Baratto, MD, and colleagues. “Using F-18 FDG-PET/MRI for assessing the cerebral impact of methotrexate therapy in pediatric cancer survivors holds the potential...
Source: AuntMinnie.com Headlines - April 8, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news

Novartis to file for Pluvicto label expansion
Novartis said it will file for a label expansion with the U.S. Food and Drug Administration (FDA) later this year to expand the use of its Pluvicto radiopharmaceutical drug to patients with earlier cases of prostate cancer. Currently, Pluvictro (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) is indicated in adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer who have previously received other anticancer therapies. The new filing follows additional data from the phase III PSMAfore study that demonstrates favorable overall survival (OS)...
Source: AuntMinnie.com Headlines - April 8, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

After life-changing losses, these millennials are now trying to help others preserve their loved ones' legacy
It wasn't until he became a father that Nicholas Worley rekindled the idea of preserving memories of his loved ones and their legacies. That idea first germinated when Worley was just 16. He lost his paternal grandfather to prostate cancer and his maternal grandmother to Alzheimer's that same year…#nicholasworley #britishcolombian #inalife #hongkong #singaporean #hareshtilani #terencechia #whartonschool #singapore #singaporeans (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

C.J. Snare Dies: Lead Singer For FireHouse Was 64
C.J. Snare, the lead singer and keyboardist of hard rock band FireHouse, which had two Top 10 singles in the early 1990s, has died at 64. Snare’s daughter said her father died on Friday after a lengthy cancer battle, with the official cause of death listed as cardiac arrest. FireHouse had seven…#cjsnare #firehouse #loveofalifetime #sleepingwithyou (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in …
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell responses up to three years and delayed tumor recurrence in patients with resected pancreatic ductal…#phase1 #bnt122 #pdac #phase2 #autogene #genentechinc #genentech #rochegroup #inest #bntx (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Geneos cancer vaccine shrinks liver tumors in small trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday. The result was roughly twice the response typically seen…#geneostherapeutics #sandiego #naturemedicine #merckandco #markyarchoan #merck #keytruda #yarchoan #rna #geneos (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 7, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
The U.S. Food and Drug Administration’s is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within…#ezekielemanuel #fda #sandiego #edwardcliff #harvardmedicalschool #jenniferlitton #houston #cherieduvalljones (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise (Source: ABC News: Health)
Source: ABC News: Health - April 7, 2024 Category: Consumer Health News Tags: Health Source Type: news

PredxBio Unveils Revolutionary SpaceIQ ™ Platform Ushering in a New Era of Spatial Multi-Omics at 2024 AACR Annual Meeting
PredxBio, a leading technology company for spatial biology solutions, is set to make waves at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) in San Diego, taking place from April 7th to 11th. Attendees are invited to explore PredxBio Booth #952, where... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 7, 2024 Category: Pharmaceuticals Tags: TDS Source Type: news

Africa: Can We End Cervical Cancer in South Sudan by 2030?
[allAfrica] Dar es Salaam, Tanzania -- In South Sudan, young Keji* experienced a life of hardships and tragedies that ultimately led to her untimely death at the age of 20. Born in an informal settlement, Keji faced the loss of her mother at the tender age of 9. By the age of 10, she was raped. She had her first child when she was 14 years old. By 15, she was diagnosed with HIV, and at 19, she was diagnosed with cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 7, 2024 Category: African Health Tags: Africa Children and Youth East Africa Health and Medicine Noncommunicable Diseases South Sudan Women and Gender Source Type: news

UltraCon: How reliable is POCUS for pancreatic imaging?
AUSTIN, TX – Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change, according to a presentation given April 7 at UltraCon. In her talk, Alice Lee, MD, from Stanford University in California highlighted findings on how POCUS can be a reliable tool for pancreatic imaging, whether performed by experienced or novice sonographers. “One of the big implications of pancreatic POCUS is the way that we put imaging in the hands of a provider who’s really managing the patient, whether it’s the gastroenterologist or the primary care physician,” Lee said. Alice Lee,...
Source: AuntMinnie.com Headlines - April 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Gastrointestinal Radiology Source Type: news

'Radiographer started crying during my cancer scan'
Molly Cuddihy shares her story in a podcast covering themes including mental health and body image. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 7, 2024 Category: Consumer Health News Source Type: news

New Prostate Cancer Cases May More Than Double To 2.9 Million By 2040
The Lancet Commission report warned that much more needs to be done urgently to address this continuing prostate cancer surge. Otherwise global deaths will rise rapidly. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 7, 2024 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news